Index RUT
P/E -
EPS (ttm) -1.32
Insider Own 8.87%
Shs Outstand 160.42M
Perf Week 0.69%
Market Cap 1.28B
Forward P/E 14.63
EPS next Y 0.55
Insider Trans -0.10%
Shs Float 146.57M
Perf Month -2.63%
Income -187.50M
PEG -
EPS next Q -0.43
Inst Own 59.80%
Short Float 26.76%
Perf Quarter -11.59%
Sales 682.16M
P/S 1.88
EPS this Y 81.77%
Inst Trans 1.97%
Short Ratio 9.05
Perf Half Y -41.40%
Book/sh -3.89
P/B -
EPS next Y 342.99%
ROA -10.84%
Short Interest 39.23M
Perf Year 60.14%
Cash/sh 5.81
P/C 1.37
EPS next 5Y 67.92%
ROE -
52W Range 3.81 - 23.86
Perf YTD -0.81%
Dividend Est. -
P/FCF -
EPS past 5Y 25.88%
ROI -
52W High -66.58%
Beta 3.05
Dividend TTM -
Quick Ratio 0.97
Sales past 5Y 516.28%
Gross Margin 71.28%
52W Low 109.32%
ATR (14) 0.56
Dividend Ex-Date Dec 13, 2007
Current Ratio 0.98
EPS Y/Y TTM 77.62%
Oper. Margin -34.00%
RSI (14) 48.43
Volatility 6.58% 7.74%
Employees 952
Debt/Eq -
Sales Y/Y TTM -30.65%
Profit Margin -27.49%
Recom 2.14
Target Price 16.43
Option/Short Yes / Yes
LT Debt/Eq -
EPS Q/Q 64.94%
Payout -
Rel Volume 0.76
Prev Close 8.38
Sales Surprise 4.66%
EPS Surprise 0.78%
Sales Q/Q -69.69%
Earnings Feb 27 BMO
Avg Volume 4.33M
Price 7.97
SMA20 1.22%
SMA50 -5.26%
SMA200 -27.44%
Trades
Volume 1,530,480
Change -4.83%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-28-25 Initiated
BTIG Research
Buy
$19
Jul-30-24 Downgrade
JP Morgan
Neutral → Underweight
$8
May-10-24 Upgrade
JP Morgan
Underweight → Neutral
May-10-24 Upgrade
BofA Securities
Underperform → Neutral
$4 → $12
Aug-09-23 Upgrade
B. Riley Securities
Neutral → Buy
$15
Apr-20-23 Downgrade
TD Cowen
Outperform → Market Perform
$55 → $10
Mar-01-23 Downgrade
B. Riley Securities
Buy → Neutral
$29 → $10
Jan-09-23 Reiterated
B. Riley Securities
Buy
$74 → $37
Dec-30-22 Reiterated
H.C. Wainwright
Buy
$207 → $110
Dec-02-22 Initiated
Jefferies
Hold
Sep-22-22 Downgrade
JP Morgan
Neutral → Underweight
$132 → $27
May-20-22 Initiated
BofA Securities
Underperform
$35
Feb-23-22 Reiterated
B. Riley Securities
Buy
$315 → $265
Feb-22-22 Resumed
Jefferies
Buy
$198
Jan-21-22 Initiated
Cowen
Outperform
$150
May-12-21 Downgrade
JP Morgan
Overweight → Neutral
$285 → $161
Dec-14-20 Initiated
Jefferies
Buy
$200
Aug-06-20 Reiterated
H.C. Wainwright
Buy
$132 → $290
Aug-05-20 Upgrade
JP Morgan
Neutral → Overweight
$275
Aug-05-20 Downgrade
Ladenburg Thalmann
Neutral → Sell
$105
Show Previous Ratings
Mar-17-25 09:00AM
Mar-15-25 07:15AM
Mar-11-25 08:00AM
Mar-08-25 11:21AM
Mar-04-25 09:00AM
08:00AM
Loading…
Feb-28-25 08:00AM
02:11AM
Feb-27-25 04:05PM
12:21PM
11:30AM
11:24AM
09:46AM
09:25AM
09:15AM
08:18AM
(Associated Press Finance)
08:06AM
Loading…
08:06AM
08:05AM
08:00AM
Feb-20-25 05:45PM
09:00AM
08:00AM
Feb-10-25 05:45PM
Feb-04-25 05:45PM
11:55AM
09:00AM
Jan-27-25 05:45PM
Jan-24-25 04:14PM
(Investor's Business Daily)
Jan-22-25 09:55AM
09:00AM
Jan-20-25 10:04PM
01:55PM
Loading…
Jan-17-25 01:55PM
(Investor's Business Daily)
Jan-15-25 05:45PM
Jan-08-25 04:03PM
09:13AM
09:13AM
09:00AM
06:09AM
Jan-07-25 04:12PM
(Investor's Business Daily) +10.86%
11:26AM
Dec-24-24 09:00AM
Dec-13-24 09:59AM
(Investor's Business Daily)
08:00AM
Dec-12-24 11:30AM
04:34AM
(Pharmaceutical Technology)
Dec-10-24 09:00AM
08:00AM
Dec-09-24 08:08PM
Dec-05-24 05:30AM
Dec-04-24 06:07AM
03:03AM
02:00AM
Nov-29-24 09:00AM
Nov-21-24 03:35PM
Nov-18-24 09:00AM
Nov-15-24 04:19PM
(Investor's Business Daily)
12:04PM
12:04PM
(Investor's Business Daily)
10:46AM
07:47AM
05:21AM
02:08AM
Nov-14-24 04:28PM
Nov-13-24 08:00AM
02:08AM
Nov-12-24 02:43PM
02:43PM
12:52PM
(Pharmaceutical Technology)
10:33AM
09:48AM
09:44AM
09:20AM
08:13AM
(Associated Press Finance)
08:05AM
08:02AM
Nov-11-24 12:49PM
09:07AM
08:58AM
08:30AM
06:53AM
Nov-08-24 01:02PM
(Investor's Business Daily)
Nov-06-24 01:13PM
Nov-05-24 10:00AM
Nov-04-24 04:30PM
06:00AM
Nov-01-24 09:00AM
Oct-29-24 05:45PM
Oct-26-24 12:29PM
12:29PM
Oct-23-24 05:45PM
Oct-22-24 04:00AM
Oct-21-24 09:00AM
07:45AM
Oct-19-24 06:15PM
Oct-17-24 05:45PM
10:07AM
08:18AM
07:08AM
Oct-16-24 04:34PM
03:50PM
01:20PM
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Trizzino John President and COO Mar 07 '25 Option Exercise 0.00 28,890 0 82,015 Mar 11 04:34 PM Kelly James Patrick EVP, CFO and Treasurer Mar 07 '25 Option Exercise 0.00 12,223 0 75,155 Mar 11 04:33 PM Trizzino John President and COO Mar 01 '25 Option Exercise 0.00 48,000 0 76,310 Mar 04 06:47 PM Casey Mark J EVP, Chief Legal Officer Mar 01 '25 Option Exercise 0.00 4,000 0 33,187 Mar 04 06:46 PM Kelly James Patrick EVP, CFO and Treasurer Mar 01 '25 Option Exercise 0.00 58,667 0 91,269 Mar 04 06:43 PM Jacobs John C President and CEO Mar 01 '25 Option Exercise 0.00 83,334 0 175,183 Mar 04 06:42 PM O'Hara Elaine EVP, Chief Strategy Officer Mar 01 '25 Option Exercise 0.00 59,600 0 73,825 Mar 04 06:39 PM Jacobs John C President and CEO Jan 23 '25 Option Exercise 0.00 83,196 0 130,722 Jan 27 06:19 PM Kelly James Patrick EVP, CFO and Treasurer Dec 31 '24 Option Exercise 0.00 35,000 0 49,508 Jan 03 05:41 PM Rodgers Richard J Director Oct 29 '24 Option Exercise 0.00 3,800 0 14,270 Jan 02 04:52 PM King Rachel K. Director Dec 13 '24 Sale 9.02 4,150 37,435 14,770 Jan 02 04:47 PM YOUNG JAMES F Director Dec 31 '24 Sale 8.00 5,400 43,200 51,760 Jan 02 04:44 PM YOUNG JAMES F Director Dec 24 '24 Sale 8.48 4,600 39,008 57,160 Jan 02 04:44 PM YOUNG JAMES F Director Dec 24 '24 Proposed Sale 8.48 10,000 84,800 Dec 26 10:31 AM Casey Mark J EVP, Chief Legal Officer Dec 11 '24 Option Exercise 0.00 41,900 0 41,900 Dec 13 05:24 PM Rachel K. King Board Member Dec 13 '24 Proposed Sale 9.00 4,150 37,350 Dec 13 12:13 PM Dubovsky Filip Officer Sep 18 '24 Proposed Sale 13.00 7,335 95,331 Sep 18 04:08 PM Trizzino John EVP, CCO and CBO Aug 19 '24 Option Exercise 0.00 655 0 28,627 Aug 21 04:47 PM Kelly James Patrick EVP, CFO and Treasurer Aug 16 '24 Option Exercise 12.96 2,367 30,676 15,652 Aug 20 05:06 PM YOUNG JAMES F Director Jun 21 '24 Sale 14.09 7,500 105,675 61,760 Jun 25 04:12 PM YOUNG JAMES F Director Jun 18 '24 Sale 13.72 7,500 102,881 69,260 Jun 21 04:21 PM Dubovsky Filip President, R&D Jun 17 '24 Option Exercise 6.18 13,904 85,911 80,517 Jun 20 05:08 PM Dubovsky Filip President, R&D Jun 17 '24 Sale 14.47 13,904 201,164 66,613 Jun 20 05:08 PM MCGLYNN MARGARET G Director Jun 12 '24 Option Exercise 0.00 6,670 0 10,470 Jun 14 04:14 PM Alton Gregg H Director Jun 12 '24 Option Exercise 0.00 6,670 0 10,470 Jun 14 04:11 PM DOUGLAS RICHARD Director Jun 12 '24 Option Exercise 0.00 6,670 0 43,920 Jun 14 04:10 PM King Rachel K. Director Jun 12 '24 Option Exercise 0.00 6,670 0 18,920 Jun 14 04:07 PM MOTT DAVID M Director Jun 12 '24 Option Exercise 0.00 6,670 0 50,470 Jun 14 04:06 PM Rodgers Richard J Director Jun 12 '24 Option Exercise 0.00 6,670 0 10,470 Jun 14 04:05 PM YOUNG JAMES F Director Jun 12 '24 Option Exercise 0.00 6,670 0 76,760 Jun 14 04:01 PM Dubovsky Filip President, R&D May 14 '24 Option Exercise 6.97 19,652 136,974 86,265 May 15 09:15 PM Dubovsky Filip President, R&D May 14 '24 Sale 13.90 47,312 657,637 38,953 May 15 09:15 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite